Results 71 to 80 of about 8,113 (209)

Bosentan and the endothelin system in congestive heart failure [PDF]

, 2000
Samer Ellahham, Wassim Choucair, Vincent Charlon, Zaid Abassi, Karim A. Calis   +4 more
openalex   +1 more source

Lower doses of bosentan in combination with sildenafil might be beneficial in pulmonary arterial hypertension

Research in Cardiovascular Medicine, 2015
Background: Endothelin-receptor-antagonist, bosentan, has been found to improve the functional capacity and cardiopulmonary hemodynamics in Pulmonary Arterial Hypertension (PAH).
Ahmad Amin, Arezoo Mohamadifar, Sepideh Taghavi, Nasim Naderi, Hosnolah Sadeghi   +4 more
doaj   +1 more source

Endothelin-1 receptors play a minor role in the protection against acute Trypanosoma cruzi infection in mice

Brazilian Journal of Medical and Biological Research, 2007
Chagas' disease, caused by the protozoan Trypanosoma cruzi, is a major cause of cardiovascular disability in countries where it is endemic. Damage to the heart microvasculature has been proposed to be an important factor in the pathogenesis of heart ...
E. Roffê, A.L.S. Souza, P.P. Machado, L.S. Barcelos, A.J. Romanha, F.S. Mariano, J.S. Silva, C.R. Machado, H.B. Tanowitz, M.M. Teixeira   +9 more
doaj  

Study on the comparison between Bosentan and Macitentan in the treatment of persistent pulmonary hypertension of the newborns, simultaneously on sildenafil: A randomized double-blinded non-inferiority parallel clinical trial

Pediatrics and Neonatology
Background: Persistent Pulmonary Hypertension of the newborn (PPHN) is characterized by sustained elevated Pulmonary Artery Pressure (PAP). Drug resistance and the adverse effects of current therapeutic agents warrant investigation of other targeted ...
Mandana Kashaki, Arash Mohazzab, Mohammad Radgoudarzi, Arash Bordbar, Sama Dabbagh   +4 more
doaj  

Endothelin Antagonism with Bosentan: Current Status and Future Perspectives [PDF]

, 2002
Koh Ono, Akira Matsumori
openalex   +1 more source

Effects of bosentan on cellular processes involved in pulmonary arterial hypertension: do they explain the long‐term benefit? [PDF]

, 2003
Martine Clozel
openalex   +1 more source

Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan [PDF]

, 2004
D. Dunbar Ivy, Aimee Doran, Lori Claussen, Deborah Bingaman, Anji T. Yetman   +4 more
openalex   +1 more source

Severe necrotising leucocytoclastic vasculitis in a patient taking bosentan [PDF]

, 2004
S Gasser, Max Kuhn, Rudolf Speich
openalex   +1 more source

1436: Bosentan, an Endothelin Dual Receptor Antagonist, Potentiates Nitric Oxide-Mediated Erectile Response in an Aging Brown-Norway Rat Model [PDF]

, 2004
Steven White, Michael Albo, Mahadevan Rajasekaran   +2 more
openalex   +1 more source

[3H]Bosentan Binding to Human Coronary Artery

, 1995
M. R. Dashwood, Maureen M. Timm, J. R. Muddle, Dinesh Shah, John R. Tippins, J C Kaski   +5 more
openalex   +1 more source